Abstract
Modern treatment for hemophilic children is based on prophylaxis and immune tolerance induction (ITI). Both treatment regimens are based on frequent infusions at early ages, therefore an adequate venous access is essential. Peripheral veins represent the best option, however, different solutions, as central venous access devices (CVADs) and arteriovenous fistulae (AVFs), can be adopted if needed. CVADs have been used in hemophiliacs, however their survival is affected by infectious complications. Among CVADs, fully implantable devices are usually preferred to external lines due to a lower infectious risk. The limited survival of CVADs may have a relevant impact on treatment outcome, especially in case of ITI where treatment interruptions are counterproductive. To overcome such drawbacks, internal AVF has been considered as an alternative option owing to a lower rate of infectious complications. Moreover, AVF is easy to use in the home setting and well accepted by children. Possible complications not preventing AVF use are postoperative hematoma and transient symptoms of distal ischemia; one case of symptomatic thrombosis has been reported so far. Long-term complications include loss of patency, aneurysmatic dilatation and, rarely, limb dysmetria and a regular follow-up is mandatory to allow early remedial intervention. Surgical dismantlement of AVF is recommended as soon as transition to peripheral veins is possible.
| Original language | English |
|---|---|
| Journal | Blood Transfusion |
| Volume | 6 |
| Issue number | SUPPL. 2 |
| DOIs | |
| Publication status | Published - 2008 |
Fingerprint
Keywords
- Arteriovenous fistula
- Catheters
- Children
- Haemophilia
- Venous access
ASJC Scopus subject areas
- Hematology
- Immunology and Allergy
Cite this
Barriers to primary prophylaxis in haemophilic children : The issue of the venous access. / Santagostino, Elena; Mancuso, Maria Elisa.
In: Blood Transfusion, Vol. 6, No. SUPPL. 2, 2008.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Barriers to primary prophylaxis in haemophilic children
T2 - The issue of the venous access
AU - Santagostino, Elena
AU - Mancuso, Maria Elisa
PY - 2008
Y1 - 2008
N2 - Modern treatment for hemophilic children is based on prophylaxis and immune tolerance induction (ITI). Both treatment regimens are based on frequent infusions at early ages, therefore an adequate venous access is essential. Peripheral veins represent the best option, however, different solutions, as central venous access devices (CVADs) and arteriovenous fistulae (AVFs), can be adopted if needed. CVADs have been used in hemophiliacs, however their survival is affected by infectious complications. Among CVADs, fully implantable devices are usually preferred to external lines due to a lower infectious risk. The limited survival of CVADs may have a relevant impact on treatment outcome, especially in case of ITI where treatment interruptions are counterproductive. To overcome such drawbacks, internal AVF has been considered as an alternative option owing to a lower rate of infectious complications. Moreover, AVF is easy to use in the home setting and well accepted by children. Possible complications not preventing AVF use are postoperative hematoma and transient symptoms of distal ischemia; one case of symptomatic thrombosis has been reported so far. Long-term complications include loss of patency, aneurysmatic dilatation and, rarely, limb dysmetria and a regular follow-up is mandatory to allow early remedial intervention. Surgical dismantlement of AVF is recommended as soon as transition to peripheral veins is possible.
AB - Modern treatment for hemophilic children is based on prophylaxis and immune tolerance induction (ITI). Both treatment regimens are based on frequent infusions at early ages, therefore an adequate venous access is essential. Peripheral veins represent the best option, however, different solutions, as central venous access devices (CVADs) and arteriovenous fistulae (AVFs), can be adopted if needed. CVADs have been used in hemophiliacs, however their survival is affected by infectious complications. Among CVADs, fully implantable devices are usually preferred to external lines due to a lower infectious risk. The limited survival of CVADs may have a relevant impact on treatment outcome, especially in case of ITI where treatment interruptions are counterproductive. To overcome such drawbacks, internal AVF has been considered as an alternative option owing to a lower rate of infectious complications. Moreover, AVF is easy to use in the home setting and well accepted by children. Possible complications not preventing AVF use are postoperative hematoma and transient symptoms of distal ischemia; one case of symptomatic thrombosis has been reported so far. Long-term complications include loss of patency, aneurysmatic dilatation and, rarely, limb dysmetria and a regular follow-up is mandatory to allow early remedial intervention. Surgical dismantlement of AVF is recommended as soon as transition to peripheral veins is possible.
KW - Arteriovenous fistula
KW - Catheters
KW - Children
KW - Haemophilia
KW - Venous access
UR - http://www.scopus.com/inward/record.url?scp=56649091115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=56649091115&partnerID=8YFLogxK
U2 - 10.2450/2008.0031-08
DO - 10.2450/2008.0031-08
M3 - Article
C2 - 19105504
AN - SCOPUS:56649091115
VL - 6
JO - Blood Transfusion
JF - Blood Transfusion
SN - 1723-2007
IS - SUPPL. 2
ER -